These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A. Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746 [Abstract] [Full Text] [Related]
3. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Schonewille H, van de Watering LM, Brand A. Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440 [Abstract] [Full Text] [Related]
8. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Castro O, Sandler SG, Houston-Yu P, Rana S. Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019 [Abstract] [Full Text] [Related]
11. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching. Ang AL, Lim CY, Ng WY, Lam JCM. Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773 [Abstract] [Full Text] [Related]
19. Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience. Belsito A, Costa D, Signoriello S, Fiorito C, Tartaglione I, Casale M, Perrotta S, Magnussen K, Napoli C. Transfus Apher Sci; 2019 Feb; 58(1):65-71. PubMed ID: 30591410 [Abstract] [Full Text] [Related]